Thus, we used NPPB, an inhibitor of anion channels that has been shown to suppress Slc26a4-induced Cl– uptake (33) and Slc26a4 activity (34), to explore whether Slc26a4 is a potential molecular target for asthma treatment. Here, SLC26A4 is linked to asthma.